Related Experiment Video
Updated: Jul 18, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophil activation in preterm infants with lung disease
E Berggren Broström1, M Katz-Salamon, J Lundahl
1Department of Pediatrics, Södersjukhuset, Karolinska Institute, Stockholm, Sweden. eva.berggren-brostrom@karolinska.se
Insights
Bronchopulmonary dysplasia (BPD) in preterm infants is linked to eosinophil activation. Eosinophil counts and activity markers were elevated in BPD infants, suggesting a role in disease pathogenesis.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Immunology
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
- The precise mechanisms underlying BPD pathogenesis remain incompletely understood.
- Eosinophils are implicated in various inflammatory lung diseases.
Purpose of the Study:
- To investigate the role of eosinophils in the pathogenesis of BPD in preterm infants.
- To compare eosinophil counts and activation markers between preterm infants with BPD, respiratory distress syndrome (RDS), and healthy controls.
Main Methods:
- Comparative study involving preterm infants with BPD (n=15), RDS (n=13), and healthy controls (n=16).
- Analysis of venous blood samples for total eosinophil and neutrophil counts.
- Measurement of eosinophilic cationic protein (ECP) and CD9 levels as markers of eosinophil activation.
Main Results:
- Significantly higher eosinophil counts were observed in infants with BPD compared to RDS and healthy infants (p=0.03).
- Elevated ECP levels (p=0.002) and reduced CD9 expression (p=0.01) in BPD infants indicate eosinophil activation.
- ECP levels correlated positively with oxygen supplementation duration; eosinophil counts decreased after steroid treatment in BPD infants.
Conclusions:
- Eosinophil activation is associated with bronchopulmonary dysplasia in preterm infants.
- These findings suggest that eosinophils may play a contributory role in the pathogenesis of BPD.
- Further research into eosinophil-targeted therapies for BPD is warranted.
Aim:
We investigated the role of eosinophils in the pathogenesis of bronchopulmonary dysplasia (BPD) in preterm infants.
Methods:
Fifteen preterm infants with BPD were compared to 13 preterms with respiratory distress syndrome (RDS) and to 16 healthy preterms. We assessed total eosinophil and neutrophil counts in venous blood samples and the levels of the eosinophilic activity markers eosinophilic cationic protein (ECP) and the cellular surface antigen (CD9).
Results:
The eosinophil count was greater in BPD compared with RDS and healthy infants (1414 vs. 797 and 471 cells per microlitre, respectively, p = 0.03). ECP levels were elevated (34 vs. 12.8 and 9.8 microg/L, respectively, p = 0.002) and CD9 levels reduced (75 vs. 94 and 86 mean fluorescence intensity units, respectively, p = 0.01) in BPD compared with RDS and healthy infants, suggesting eosinophilic activation in BPD. These findings were not solely explained by differences between gestational age or birth weight of the different groups. ECP levels were positively correlated with the duration of oxygen supplementation in the BPD group. The eosinophil count fell promptly after steroid treatment was commenced in the BPD group.
Conclusion:
The findings suggest that BPD is linked to eosinophil activation, which might contribute to the pathogenesis.
Related Concept Videos
Asthma I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Respiratory Syncytial Virus Disease
Breathing
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.